CSE listed biotech shares rose an average 69% in 2004  

2005.02.02
Shares of biotech companies Bavarian Nordic, Genmab, NeuroSearch and Pharmexa, listed on Copenhagen Stock Exchange, increased by an average 69% in 2004

Shares of biotech companies Bavarian Nordic, Genmab, NeuroSearch and Pharmexa, listed on Copenhagen Stock Exchange, increased by an average 69% in 2004, a significantly better performance than biotech shares worldwide which saw an average growth of only 8%. Hanne Hillman, portfolio manager at BankInvest says that 2005 also could be a very good year for Danish biotech.

 

Michael Novod, analyst at Handelsbanken shares this view, and says the low interest rate gives an attractive risk/ROI relationship on biotech shares. In addition, pharmaceutical companies need new products which ensure a market for research activities in the biotech industry: "The large pharmaceutical companies need to fill the pipeline, which will have a positive rub-off effect on biotech companies", he says. The news is reported by daily financial newspaper Børsen.

 

Link > Copenhagen Stock Exchange 

Next step

Explore business cases

Please contact me

Name
Company
E-mail
Phone
How can we help you?

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×